Double-blind, randomized clinical trial targeting theta oscillations with transcranial alternating current stimulation (tACS) for cognitive control in male methamphetamine patients
In brief
Fifteen days of theta brain stimulation improved cognitive control in men with methamphetamine use disorder
In a randomized, sham-controlled trial, 56 men who completed 15 daily sessions of theta-frequency brain stimulation showed better preparation for stopping and a higher inhibition rate. EEG results linked the gains to stronger brain activity during proactive control, but the study did not establish whether benefits last or reduce methamphetamine use.
- Journal
- Molecular psychiatry (Q1)
- Published
- 29 September 2026
- Study design
- Randomized controlled trial
- Evidence level
- Level 1, High (CEBM 1b)
- Authors
- Yang Tian, Linjun Jiang, Xianchen Gang, Meng Chen, Shanshan Tang, Xiaotao Wang, et al.
- PMID
- 42811072
- DOI
- 10.1038/s41380-026-03900-0
Why clinicians should know about it
- Picked for Psychiatry and Mental Health (top studies of the week, 4 October 2026): Double‑blind RCT, tACS improves cognitive control in meth users
Abstract
Methamphetamine use disorder is associated with significant cognitive control deficits, and effective treatments remain limited. Frontal midline theta (FM-theta) oscillations are implicated in cognitive control, but whether theta-frequency transcranial alternating current stimulation (theta-tACS) can improve proactive and reactive control in this population remains unclear. This study initially enrolled 68 male participants diagnosed with methamphetamine use disorder according to DSM-5 criteria. Among them, 56 individuals completed all study procedures and were included in the final analysis. Cognitive control was assessed using a conditional stop-signal task with concurrent EEG recording. The stimulation protocol comprised 15 consecutive daily sessions, during which participants received either active theta-tACS or sham stimulation (2 mA, FCz - Pz montage) in a double-blind design. Following the 15-day theta-tACS stimulation, patients exhibited a significant improvement in preparation cost (p = 0.001) and an increased inhibition rate (p = 0.003). EEG analyses showed that tACS selectively enhanced late-stage proactive control-related theta power (p = 0.026), without significantly modulating theta activity associated with reactive control (p > 0.05). Importantly, the tACS stimulation restored the functional coupling between FM-theta activity and proactive control performance (p = 0.04), and baseline late-stage theta power at T0 positively predicted improvement in preparation cost (ΔT1 - T0) during proactive control (p = 0.01). Finally, a mediation analysis revealed that the tACS-induced improvement in inhibition rate was mediated by the enhanced preparation cost. These findings suggested theta-tACS enhances proactive control by restoring the functional coupling between FM-theta activity and proactive control, which in turn triggers a cascading improvement in reactive control.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.